LifeMD Reports Fourth Quarter 2024 Results
Portfolio Pulse from
LifeMD, Inc. reported strong financial results for Q4 2024, with a 43% increase in consolidated revenues and a 60% rise in telehealth revenue. The company also saw a significant increase in adjusted EBITDA and cash flow. LifeMD introduced 2025 guidance with expected revenue between $265 million and $275 million.
March 10, 2025 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LifeMD, Inc. reported a 43% increase in Q4 2024 revenues and a 60% rise in telehealth revenue. Adjusted EBITDA grew by 78%, and the company introduced strong 2025 guidance.
LifeMD's significant revenue and EBITDA growth, along with positive cash flow and strong 2025 guidance, are likely to positively impact its stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100